Prognostic impact of shift to low visceral fat mass after neoadjuvant chemotherapy in patients with esophageal cancer.

Sachiyo OnishiMasahiro TajikaTsutomu TanakaKeisaku YamadaYoshitaka InabaTetsuya AbeKei MuroMasahito ShimizuYasumasa Niwa

Published in: Cancer reports (Hoboken, N.J.) (2024)

This study suggests that prevention of the shift to low visceral fat throughout the neoadjuvant chemotherapy process should improve patient outcomes.

Keyphrases